Aziridine → azetidin-1-yl(1-{4-[(1-cyclobutylpiperidin-4-yl)oxy]phenyl}-1H-pyrrol-3-yl)methanone
반응식
[CH:1]1([N:5]2[CH2:10][CH2:9][CH:8]([O:11][C:12]3[CH:17]=[CH:16][C:15]([N:18]4[CH:22]=[CH:21][C:20]([C:23](O)=[O:24])=[CH:19]4)=[CH:14][CH:13]=3)[CH2:7][CH2:6]2)[CH2:4][CH2:3][CH2:2]1.Cl.CN(C)CCCN=[C:33]=[N:34][CH2:35][CH3:36].O.ON1C2C=CC=CC=2N=N1.N1CC1>CN(C)C=O.C(Cl)(Cl)Cl.O>[N:34]1([C:23]([C:20]2[CH:21]=[CH:22][N:18]([C:15]3[CH:14]=[CH:13][C:12]([O:11][CH:8]4[CH2:7][CH2:6][N:5]([CH:1]5[CH2:2][CH2:3][CH2:4]5)[CH2:10][CH2:9]4)=[CH:17][CH:16]=3)[CH:19]=2)=[O:24])[CH2:33][CH2:36][CH2:35]1참가 물질
8
반응물 4
생성물 1
시약·촉매·용매 3
실험 절차
A suspension of 1-{4-[(1-cyclobutylpiperidin-4-yl)oxy]phenyl}-1H-pyrrole-3-carboxylic acid (0.1 g) synthesized in Example 2, 1-{3-(dimethylamino)propyl}-3-ethylcarbodiimide hydrochloride (0.085 g), 1-hydroxybenzotriazole hydrate (0.067 g) and aziridine (0.034 g) in N,N-dimethylformamide (0.1 ml) was stirred at room temperature for 16 hours. Water was added to the reaction mixture and extraction was conducted with chloroform. The organic layer was concentrated under reduced pressure and the resulting residue was purified by silica gel column chromatography (NH form silica gel; eluent: n-hexane/ethyl acetate=88/12-0/100) to give the titled compound as a colorless solid (0.056 g).
후처리
- concentrationThe organic layer was concentrated under reduced pressure
- customthe resulting residue was purified by silica gel column chromatography (NH form silica gel; eluent: n-hexane/ethyl acetate=88/12-0/100)
출처 및 근거
- ORD 기록
- ord-5d8b65265af646478daa7ca17f90e174
- 출처 데이터셋
- uspto-grants-2016_03
- 특허 번호
- US09284324B2
반응 노트
불러오는 중…